Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-107001
Filing Date
2025-11-05
Accepted
2025-11-05 16:14:14
Documents
96
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pahc-20250930x10q.htm   iXBRL 10-Q 1839844
2 EX-31.1 pahc-20250930xex31d1.htm EX-31.1 8059
3 EX-31.2 pahc-20250930xex31d2.htm EX-31.2 8029
4 EX-32.1 pahc-20250930xex32d1.htm EX-32.1 3782
5 EX-32.2 pahc-20250930xex32d2.htm EX-32.2 4052
  Complete submission text file 0001104659-25-107001.txt   8990238

Data Files

Seq Description Document Type Size
6 EX-101.SCH pahc-20250930.xsd EX-101.SCH 62496
7 EX-101.CAL pahc-20250930_cal.xml EX-101.CAL 94182
8 EX-101.DEF pahc-20250930_def.xml EX-101.DEF 330775
9 EX-101.LAB pahc-20250930_lab.xml EX-101.LAB 477966
10 EX-101.PRE pahc-20250930_pre.xml EX-101.PRE 507652
99 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20250930x10q_htm.xml XML 1559951
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 251454162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)